All posts by: Michael Zand

About Michael Zand

Hebrew U’s Dr. Yosef Buganim Awarded for Work in Stem Cells – The Jewish Press

Continue reading

2016-07-18 NEWS

The Jewish Press

Hebrew U’s Dr. Yosef Buganim Awarded for Work in Stem Cells
The Jewish Press
Awarded for the first time this year, the Boyalife Science & Science Translational Medicine Award in Stem Cells & Regenerative Medicine honors researchers for outstanding contributions in stem cell research and regenerative medicine around the globe.

Continue reading

2016-07-18 NEWS

Stem Cell Banking Market Worth 3.96 Billion USD by 2021
PR Newswire (press release)
According to a new market research report ” Stem Cell Banking Market by Bank Type (Cord Blood, and Cord Tissue), Service (Collection & Transportation, Analysis, Processing, and Storage), Application (Cerebral Palsy, Leukemia, Thalassemia, Anemia, …

and more »

Continue reading

2016-07-18 NEWS

ChristianToday

HIV/AIDS cure news: Stem cell transplantation being considered a possible albeit complicated approach
ChristianToday
Known as the EPISTEM project, the HIV positive patients involved in it received the said stem cell transplants. Because of this, their HIV reservoirs plummeted low levels. “In two of the three patients we were unable to detect infectious virus in the
HIV cure study provides insight into 2008 caseCNN
Berlin Man:Timothy Ray Brown,the man who once had HIV and the first man to be cured of itIndia Live Today
Will there ever be a cure for the deadly HIV?Jamaica Observer

all 26 news articles »

Continue reading

2016-07-18 NEWS

TheStreet.com

Brainstorm: New ALS Stem Cell Results Support Start of Pivotal Clinical Trial
TheStreet.com
More patients with amyotrophic lateral sclerosis (ALS) had a positive response to an injection of an experimental stem cell therapy developed by Brainstorm Cell Therapeutics (BCLI) compared to similar ALS patients given a placebo, according to results
Brainstorm’s Cell Therapy Succeeds In ALS Mid-Stage StudyMedical Daily
Brainstorm Cell Therapeutics Inc. (NASDAQ: BCLI) Is About To Release Clinical Study ResultsScibility Media
Shares of Brainstorm Cell Therapeutics (BCLI) Rally 17.26%TheFounders Daily
Seeking Alpha –The Voice Registrar –Zergwatch
all 22 news articles »